ArticleBMC medical education2026
Pharmacists' perspectives on medication therapy management training needs for chronic disease care in Indonesian primary healthcare centers: a qualitative study across 32 provinces.
Article in BMC medical education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic diseases place a growing burden on health systems and require effective strategies to support long-term medication use. Medication Therapy Management (MTM) has been shown to improve clinical outcomes in chronic disease care, but its implementation depends on pharmacists' competencies and access to structured training. In Indonesia, MTM remains inconsistently implemented in primary healthcare centers (PHCs), and pharmacists have reported competency gaps in the absence of standardized training. Evidence to inform context-specific training design is limited. The objective of this study was to explore and identify Indonesian PHC pharmacists' perspectives on training for chronic-disease MTM, including their needs, preferences, perceived challenges, and facilitators.
methodsThis paper reports the qualitative component of a larger mixed-methods study. A qualitative descriptive study was conducted using six focus group discussions (FGDs) with 32 PHC pharmacists from 32 provinces in Indonesia. Participants were purposively selected based on their experience in PHCs (≥ 6 months). All audio recordings were transcribed verbatim and then analyzed using an inductive thematic approach in Atlas.ti. To strengthen the credibility of the findings, we used triangulation, member checking, and peer debriefing during the analysis.
resultsThe analysis generated four themes: needs, preferences, challenges, and facilitators. Pharmacists emphasized a need for standardized, competency-based, and practice-oriented MTM training. They strongly preferred content that aligned with daily practice and focused on prevalent chronic diseases. However, they also identified several contextual challenges that might influence implementation, including geographical and cost barriers, limited digital access, and competing responsibilities. Institutional and policy support, as well as post-training mechanisms, were considered factors that may facilitate learning sustainability and implementation in routine care.
conclusionsPharmacists in Indonesian PHCs perceive clear needs, preferences, challenges, and facilitators for MTM training. These findings can inform the development of context-sensitive, competency-based training programs. Embedding such training into continuing professional development frameworks is recommended to strengthen its sustainability and long-term impact, contributing to health professions education for primary care pharmacists.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.